Vetmedin Solution for Dogs, 1.5 mg/mL, 50 mL

Vetmedin
Item #5370079
Prescription item
Fulfilled by Allivet
$74.49
Quantity:
1 Count
Choose size
    Sign In & Enjoy Free Shipping Over $49
    Prescription info required
    • Most orders ready within 2 hours
    •  
    • Out of stock
    About this item
    DESCRIPTION

    VETMEDIN Solution (pimobendan oral solution) is the only oral solution product approved by the FDA. According to published studies, it helps with the management of the signs of congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). ², ³ Given every 12 hours, the unique dual action of VETMEDIN dilates the blood vessels carrying blood to and from the heart - reducing the preload and afterload on the heart - while simultaneously improving contractility of the heart muscle.1 Pimobendan, VETMEDIN's active ingredient, reduces stress on the heart while increasing cardiac output, without raising oxygen or energy consumption. VETMEDIN helps dogs engage in the daily activities they enjoy. Increasing age is a risk factor for heart disease and heart failure.4 With early diagnosis and treatment of clinical signs, you can significantly prolong your dog's survival time and improve their quality of life. As shown in previous studies ², ³ Be sure to talk to your veterinarian about VETMEDIN oral solution if your dog is in heart failure to determine the proper treatment for your pet.

    References: 1. VETMEDIN® Solution (pimobendan oral solution) [Freedom of Information Summary; NADA 141-273]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2007. 2. Häggström J, Boswood A, O´Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124-1135. 3. Lombard CW, Jöns O, Bussadori CM; for the VetSCOPE Study. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249-261. 4. Keene et al ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs J Vet Intern Med 2019.

    Formulated For: Dogs

    What Form Does Medication Come In? 50mL Bottle

    Dose and Administration: Use as directed by your Veterinarian

    Uses: Congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM)

    Possible Side Effects: The most common side effects are poor appetite, lethargy, diarrhea, shortness of breath, weakness, and ataxia (lack of muscle control and coordination). If side effects occur, consult your veterinarian. The safety of VETMEDIN® Solution (pimobendan oral solution) inodilator has not been established in puppies younger than 6 months of age, or in breeding, pregnant or lactating dogs. For more information, please see full prescribing information.

    From the manufacturer